Ken‐ichi Kozaki - Concepedia

Concepedia

Author

Ken‐ichi Kozaki

Tokyo Medical and Dental University

Also Known As

K I Kozaki, K Kozaki, K.-i. Kozaki, Ken-Ichi Kozaki, Ken-ichi Kozaki, Ken‐ichi Kozaki, Kozaki K

39

Publications

3.5K

Citations

29

H-Index

75

Concepts

All Affiliations

Tokyo Medical and Dental University Aichi Cancer Center Okayama University Nagoya University Harvard University

KK

About

Ken‐ichi Kozaki is an author at Tokyo Medical and Dental University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	961
2	Natural Sciences	3	3	88
3	Health Sciences	1	1	107
4	Allergy	1	1	13
5	Biochemistry	1	1	22

Ken‐ichi Kozaki

×

35

Publications

3.5K

Citations

29

H-Index

	Year	Citations
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer Ken‐ichi Kozaki, Issei Imoto, Seiki Mogi, Cancer Research	2008	617
Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling Yulong He, Ken‐ichi Kozaki, Terhi Kärpänen, JNCI Journal of the National Cancer Institute	2002	511
The Tumor Suppressive MicroRNA <i>miR-218</i> Targets the mTOR Component <i>Rictor</i> and Inhibits AKT Phosphorylation in Oral Cancer Atsushi Uesugi, Ken‐ichi Kozaki, Tomohiko Tsuruta, Cancer Research	2011	250
YAP is a candidate oncogene for esophageal squamous cell carcinoma Tomoki Muramatsu, Issei Imoto, Takeshi Matsui, Carcinogenesis	2010	230
<i>miR-152</i> Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer Tomohiko Tsuruta, Ken‐ichi Kozaki, Atsushi Uesugi, Cancer Research	2011	228
Significant growth inhibition of human lung cancer cells both in vitro and in vivo by the combined use of a selective cyclooxygenase 2 inhibitor, JTE-522, and conventional anticancer agents. Toyoaki Hida, Ken‐ichi Kozaki, Hidemi Ito, PubMed ImmunologyPharmacotherapyTumor BiologyOncologySelective Cox-2 Inhibitor	2002	113
Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer Raimundas Lunevičius, Hayao Nakanishi, Seiji Ito, Journal of Cancer Research and Clinical Oncology HepatologyMedicineLiver PhysiologySurgical PathologyPathology	2001	107
Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab Toshifumi Fujiwara, Takanori Eguchi, Chiharu Sogawa, Oral Oncology	2018	106
Frequent silencing of protocadherin 17 , a candidate tumour suppressor for esophageal squamous cell carcinoma Shigeo Haruki, Issei Imoto, Ken‐ichi Kozaki, Carcinogenesis	2010	94
Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (<i>MTNR1A</i>) in oral squamous‐cell carcinoma Erina Nakamura, Ken‐ichi Kozaki, Hitoshi Tsuda, Cancer Science	2008	86

Page 1